Evidence map›Paper›PMID 30705386›Full record

ArticleScientific reports2019

In Vivo Response of Acellular Porcine Pericardial for Tissue Engineered Transcatheter Aortic Valves.

Reza Khorramirouz, Jason L Go, Christopher Noble, David Morse, Amir Lerman, Melissa D Young

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Biocompatibility and effect on bone formation of a native acellular porcine pericardium: Results ofBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021
    Article
  6. Review
  7. Perigraft reaction and incorporation of porcine and bovine pericardial patches.Interactive cardiovascular and thoracic surgery · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Reza KhorramirouzDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Jason L GoDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Christopher NobleDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
David MorseDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Amir LermanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Melissa D YoungDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. young.melissa@mayo.edu.ORCID 0000-0002-4114-7768
Mayo Clinic in Arizona · US

Funding

CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
NHLBI NIH HHS T32 HL007111
6 · The paper itself

Abstract

Current heart valve prostheses have limitations that include durability, inability to grow in pediatric patients, and lifelong anticoagulation. Transcatheter aortic valve replacements are minimally invasive procedures, and therefore have emerged as an alternative to traditional valve prostheses. In this experiment, the regenerative capacity of potential tissue engineered transcatheter valve scaffolds (1) acellular porcine pericardium and (2) mesenchymal stem cell-seeded acellular porcine pericardium were compared to native porcine aortic valve cusps in a rat subcutaneous model for up to 8 weeks. Immunohistochemistry, extracellular matrix evaluation, and tissue biomechanics were evaluated on the explanted tissue. Acellular valve scaffolds expressed CD163, CD31, alpha smooth muscle actin, and vimentin at each time point indicating host cell recellularization; however, MSC-seeded tissue showed greater recellularization. Inflammatory cells were observed with CD3 biomarker in native porcine pericardial tissue throughout the study. No inflammation was observed in either acellular or MSC-seeded scaffolds. There was no mechanical advantage observed in MSC-seeded tissue; however after the first week post-explant, there was a decrease in mechanical properties in all groups (p < 0.05). MSC-seeded and acellular porcine pericardium expressed decreased inflammatory response and better host-cell recellularization compared to the native porcine aortic valve cusps.

Indexed as

Aortic ValveBioprosthesisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAnimalsMesenchymal Stem CellsPericardiumRatsRats, Sprague-DawleySwineTissue Engineering

Identifiers

PMID30705386
PMCPMC6355869
OpenAlexW2918805485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.